IQ-AI subsidiary receives US access programme approval for brain cancer treatment

1 year ago 36

IQ-AI subsidiary Imaging Biometrics has received approval for an Expanded Access Program (EAP) for oral gallium maltolate (GaM) from the US Food and Drug...

1. Homepage
2. Brain Cancer
3. IQ-AI subsidiary receives US access programme approval for brain cancer treatment